YAP1与RNA分子m6A修饰配合对胃癌化疗敏感性的影响

doi:10.3969/j.issn.1006-6233.2023.11.08

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (2221 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To investigate the effect of the interaction between Yes-associated protein 1 (YAP1) and RNA molecule N6-methyladenosine (m6A) modification on the chemosensitivity of gastric cancer (GC). Methods: Cisplatin-resistant AGS/DDP cells and their cisplatin-sensitive parental AGS cells were used as cell models.The expression of methyltransferase-like 3 (METTL3) and YAP1 proteins was analyzed using immunoblotting,and the extent of m6A modification was determined by Poly(A) RNA dot blotting.The influence of METTL3-induced m6A modification on YAP1 translation was assessed using a luciferase reporter gene.The impact of cisplatin treatment on apoptosis in METTL3- or YAP1-knockout AGS/DDP cells was examined by Tunel.A mouse xenograft model was established to study the effect of METTL3 knockout on cisplatin sensitivity in vivo. Results: The expression of m6A methyltransferase METTL3 was elevated in AGS/DDP cells,a cisplatin-resistant subline of GC cells,in comparison to the parental cells.METTL3 increased the m6A modification of YAP1 mRNA in AGS/DDP cells,enhancing its translation efficiency.Conversely,knockout of METTL3 in AGS/DDP cells reduced YAP1 expression and restored cisplatin sensitivity.Cisplatin treatment following METTL3 knockout induced apoptosis in AGS/DDP cells and reduced tumor growth derived from AGS/DDP cells in BALB/c nude mice. Conclusion: METTL3-induced m6A modification plays a significant role in acquired cisplatin resistance by promoting YAP1 upregulation,suggesting that METTL3 may be a potential candidate for targeted chemotherapy in GC.

Key words： Yes-related protein 1 N6-methyladenosine Gastric cancer Methyltransferase-like 3 Cisplatin

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2023.11.08 OR http://www.hbyxzzs.cn/EN/Y2023/V29/I11/1800

[1] 张维汉,杨昆,陈心足,等.规范化外科手术与多学科综合治疗对胃癌患者预后的影响:一项单中心队列研究报告[J].中华胃肠外科杂志,2020,23(4):396-404.
[2] Yue B,Song C,Yang L,et al.METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer[J].Mol Cancer,2019,18(1):142.
[3] Liu T,Yang S,Sui J,et al.Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer[J].Cell Physiol,2020,235(1):548-562.
[4] Chen H,Xiang Y,Yin Y,et al.The m6A methyltransferase METTL3 regulates autophagy and sensitivity to cisplatin by targeting ATG5 in seminoma[J].Transl Androl Urol,2021,10(4):1711-1722.
[5] Wang W,Shao F,Yang X,et al.METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N6-methyladenosine-dependent YTHDF binding[J].Nat Commun,2021,12(1):3803.
[6] Jin D,Guo J,Wu Y,et al.m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC[J].Mol Cancer,2020,19(1):40.
[7] 杨振,张红珠,张伟,等.Yes相关蛋白1对胃癌顺铂化疗敏感性的影响及作用机制初探[J].国际医药卫生导报,2021,27(21):3381-3387.
[8] 汪圣毅,程彦,李旭升,等.胃癌顺铂抵抗相关免疫标记基因的富集分析[J].安徽医科大学学报,2020,55(2):200-204.
[9] Zhang J,Zhou Y,Tang P M K,et al.Mechanotransduction and cytoskeleton remodeling shaping YAP1 in gastric tumorigenesis[J].Int Mol Sci,2019,20(7):1576.
[10] Pan J,Liu F,Xiao X,et al.METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis[J].Exp Clin Cancer Res,2022,41(1):19.
[11] 程子硕,刘丽华.m6A甲基化在肿瘤发生发展中作用的研究进展[J].中国肿瘤生物治疗杂志,2020,27(10):1183-1189.
[12] 孙善文,雍红梅,周学义.m6A与mRNA代谢及其与恶性肿瘤关系的研究进展[J].现代肿瘤医学,2020,28(10):1781-1786.
[13] Li S,Ji J,Zhang Z,et al.Cisplatin promotes the expression level of PD-L1 in the microenvironment of hepatocellular carcinoma through YAP1[J].Mol Cell Biochem,2020,475(1-2):79-91.
[14] He K,Li Z,Ye K,et al.Novel sequential therapy with metformin enhances the effects of cisplatin in testicular germ cell tumours via YAP1 signalling[J].Cancer Cell Int,2022,22(1):113.
[15] Chen W,Hu J,He Y,et al.The interaction between SMAD1 and YAP1 is correlated with increased resistance of gastric cancer cells to cisplatin[J].Appl Biochem Biotechnol,2022,195(10):6050-6067.
[16] Bedi R K,Huang D,Eberle S A,et al.Small-molecule inhibitors of METTL3,the major human epitranscriptomic writer[J].Chem Med Chem,2020,15(9):744-748.